Fungemia remains a major threat in intensive care units (ICUs), with high mortality rates despite advances in diagnostics and treatment. Colonisation by yeasts is an independent risk factor for fungemia; however, its predictive utility requires further research. In this 8-year study, we analysed 38,017 samples from 3206 patients and 171 fungemia episodes as part of a weekly fungal surveillance programme. We evaluated species-specific colonisation patterns, the predictive value of the Colonisation Index (CI) and Corrected Colonisation Index (CCI), and candidemia risks associated with different yeast species and anatomical site colonisation. Our results showed that C. auris, N. glabratus, and C. parapsilosis colonisation increased with longer hospital stays (0.8% to 11.55%, 8.13% to 16.8%, and 1.93% to 5.14%, respectively). The CI and CCI had low discriminatory power (AUROC 67% and 66%). Colonisation by any yeast genera demonstrated high sensitivity (98.32%) and negative predictive value (NPV) (95.90%) but low specificity and positive predictive value (PPV) (23.90% and 6.64%). Tracheal and urine cultures had the highest PPV (15.64% and 12.91%), while inguinal cultures had the highest NPV (98.60%). C. auris (12.32%) and C. parapsilosis (5.5%) were associated with a higher fungemia risk (log-rank < 0.001). These findings support the use of weekly surveillance to better stratify the fungemia risk and optimise antifungal use in ICUs.
1 November 2026 in Expert Review of Anti-infective Therapy
1. Candidemia is the most frequent invasive fungal infection in hospitalized patients (0.8-2.2 per 1,000 admissions, up to 6.7 in intensive care units) and carries a mortality of 30-60% [1,2]. To r...
22 February 2023 in European Annals of Otorhinolaryngology, Head and Neck Diseases
Background: Surveillance cultures for multidrug-resistant Gram-negative bacteria are increasingly used to guide empirical therapy in allo-HSCT recipients, yet whether the antimicrobial susceptibility profile of the colonising isolate reliably predicts that of the infecting strain remains poorly characterised. The aim of the study was to evaluate antimicrobial susceptibility concordance between colonising and bloodstream extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) and carbapenem-resistant Enterobacterales (CRE) isolates in allo-HSCT patients, assess surveillance culture performance as BSI predictors, and examine whether concordance varies by timing. Methods: Retrospective cohort of 872 adult allo-HSCT recipients (2015–2024). Weekly rectal and oropharyngeal surveillance cultures were performed to detect ESBL-E and CRE. Categorical agreement between surveillance and bloodstream isolates was evaluated using the earliest and most recent surveillance cultures as reference. Factors associated with concordance were analysed using logistic regression. Results: Of 338 colonised patients, 47 developed BSI by the same organism. Rectal cultures showed high sensitivity (CRE 74.1%, ESBL-E 69.0%) with negative predictive value≥95%; oropharyngeal cultures were independently associated with CRE BSI. Full concordance was 33.3% with the earliest isolate and 53.3% with the most recent; specific β-lactam concordance improved from 36.7% to 70.0% (p<0.01). Each additional 7 days between the most recent surveillance culture and BSI onset independently reduced the odds of β-lactam concordance by approximately 15% (aOR 0.85 [0.74–0.98], p<0.05). ESBL-E phenotype was the dominant predictor of overall concordance (aOR 6.23 [1.1–34.1], p<0.05). Conclusions: The most recent surveillance isolate substantially outperforms the earliest as an empirical reference. The predictive value of surveillance culture antibiograms is time-dependent and mechanism-specific and should be interpreted accordingly.